SMS Pharmaceuticals is currently trading at Rs. 443.60, up by 7.95 points or 1.82% from its previous closing of Rs. 435.65 on the BSE.
The scrip opened at Rs. 440.00 and has touched a high and low of Rs. 445.05 and Rs. 428.65 respectively. So far 825 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 585.00 on 23-Sep-2014 and a 52 week low of Rs. 155.00 on 28-Nov-2013.
Last one week high and low of the scrip stood at Rs. 460.00 and Rs. 408.00 respectively. The current market cap of the company is Rs. 362.86 crore.
The promoters holding in the company stood at 63.91 % while Institutions and Non-Institutions held 0.53 % and 35.55 % respectively.
SMS Pharmaceuticals’ legal disputes with Natco Pharma have been amicably settled. Out of the settlement, the Company has received a sum of Rs 15.07 crores from Natco Pharma apart from the balance principal amount receivable from the respective courts.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. The company is diversifying into CRAMS by creating research and manufacturing facilities bettering the requirements of the regulatory markets to appeal to international clientele.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1807.25 |
| Dr. Reddys Lab | 1273.90 |
| Cipla | 1388.80 |
| Zydus Lifesciences | 1104.35 |
| Lupin | 2292.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: